个人中心 - 老虎社区

SoulMetta

IP属地：未知

帖子 · 17帖子 · 17
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- SoulMettaSoulMetta
  ·2021-12-19
  Good notes
  Microsoft's top priority for 2022? It could be data management<blockquote>微软2022年的首要任务？可能是数据管理</blockquote>
  Microsoft might have its work cut out for it when it comes to improving on how things went overall
  Microsoft's top priority for 2022? It could be data management<blockquote>微软2022年的首要任务？可能是数据管理</blockquote>
  1,554 评论
  2
  分享
  举报
- SoulMettaSoulMetta
  ·2021-11-29
  $SINGAPORE AIRLINES LTD(C6L.SI)$Not going topanic 🥶 cool 😎
  1,845 评论
  3
  分享
  举报
- SoulMettaSoulMetta
  ·2021-11-29
  $Novavax(NVAX)$sold last week and pocketed 🤑
  1,678 评论
  3
  分享
  举报
- SoulMettaSoulMetta
  ·2021-11-28
  [Smile]
  非常抱歉，此主贴已删除
  1,415 评论
  4
  分享
  举报
- SoulMettaSoulMetta
  ·2021-11-22
  $Novavax(NVAX)$I was told it will go up till $279 & I have been waiting 😆
  3,458 2
  5
  分享
  举报
- SoulMettaSoulMetta
  ·2021-11-18
  [Strong] [Strong]
  非常抱歉，此主贴已删除
  1,581 评论
  3
  分享
  举报
- SoulMettaSoulMetta
  ·2021-11-02
  Waiting for you
  Novavax COVID-19 vaccine gets first authorization; expects more within weeks, CEO says<blockquote>Novavax新冠肺炎疫苗获得首次授权；首席执行官表示，预计几周内会有更多</blockquote>
  (Reuters) -Novavax Inc expects regulators in India, the Philippines and elsewhere to make a decision
  Novavax COVID-19 vaccine gets first authorization; expects more within weeks, CEO says<blockquote>Novavax新冠肺炎疫苗获得首次授权；首席执行官表示，预计几周内会有更多</blockquote>
  1,552 1
  4
  分享
  举报
- SoulMettaSoulMetta
  ·2021-11-02
  Tesla over priced. Short term
  非常抱歉，此主贴已删除
  1,503 评论
  6
  分享
  举报
- SoulMettaSoulMetta
  ·2021-10-21
  $Barrick Gold Corp(GOLD)$Going up up up
  1,455 评论
  1
  分享
  举报
- SoulMettaSoulMetta
  ·2021-10-14
  $Barrick Gold Corp(GOLD)$💪🏻
  1,726 评论
  点赞
  分享
  举报
暂无粉丝

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4094873086317940","uuid":"4094873086317940","gmtCreate":1631770228090,"gmtModify":1632625772196,"name":"SoulMetta","pinyin":"soulmetta","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/e8ddb558fb5f336f0f9ac37f8e492989","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":8,"headSize":15,"tweetSize":17,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.04.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.04","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"02aa7f16703b4ce4ace6f1a7665789cc-1","templateUuid":"02aa7f16703b4ce4ace6f1a7665789cc","name":"知识体验官","description":"观看学堂课程满5节","bigImgUrl":"https://static.tigerbbs.com/fb5ae275631fb96a92d475cdc85d2302","smallImgUrl":"https://static.tigerbbs.com/c2660a1935bd2105e97c9915619936c3","grayImgUrl":null,"redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":2006,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":699433302,"gmtCreate":1639873991669,"gmtModify":1639873991776,"author":{"id":"4094873086317940","authorId":"4094873086317940","name":"SoulMetta","avatar":"https://static.tigerbbs.com/e8ddb558fb5f336f0f9ac37f8e492989","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094873086317940","authorIdStr":"4094873086317940"},"themes":[],"title":"","htmlText":"Good notes","listText":"Good notes","text":"Good notes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699433302","repostId":"1157504157","repostType":4,"repost":{"id":"1157504157","kind":"news","pubTimestamp":1639872188,"share":"https://www.laohu8.com/m/news/1157504157?lang=zh_CN&edition=full","pubTime":"2021-12-19 08:03","market":"us","language":"en","title":"Microsoft's top priority for 2022? It could be data management<blockquote>微软2022年的首要任务？可能是数据管理</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1157504157","media":"Seeking Alpha","summary":"Microsoft  might have its work cut out for it when it comes to improving on how things went overall ","content":"<p><a href=\"https://laohu8.com/S/MSFT\">Microsoft </a> might have its work cut out for it when it comes to improving on how things went overall for it in 2021.</p><p><blockquote><a href=\"https://laohu8.com/S/MSFT\">微软</a>在改善2021年的整体状况方面，它可能还有很多工作要做。</blockquote></p><p> After all, the software giant's earnings results continue to show it growing in areas such as cloud computing and personal computers. Microsoft (MSFT) also thinks so highly of its outlook that it believes it could surpass $50 billion in quarterly revenue for the first time with its next report. Investors should also be pleased with how Microsoft (MSFT) has performed on the stock market this year, as its shares have climbed more than 44% since the end of 2021.</p><p><blockquote>毕竟，这家软件巨头的盈利结果继续显示其在云计算和个人电脑等领域的增长。微软(MSFT)也高度评价其前景，相信在下一份报告中，其季度收入可能会首次超过500亿美元。投资者还应该对微软(MSFT)今年在股市上的表现感到满意，因为自2021年底以来，其股价已上涨超过44%。</blockquote></p><p> And then there was the symbolic, if temporary, victory Microsoft (MSFT) could claim in October when it briefly took the title of World's Most Valuable Company away from Apple (NASDAQ:AAPL). So, needless to say, 2021 has been a good year for Microsoft (MSFT).</p><p><blockquote>然后，微软(MSFT)在10月份短暂地从苹果(纳斯达克股票代码：AAPL)手中夺走了全球最有价值公司的称号，尽管是暂时的。因此，不用说，2021年对于微软(MSFT)来说是美好的一年。</blockquote></p><p> But, this begs the question of what 2022 might look like for Microsoft (MSFT), and what are going to be the top priorities for Chief Executive Satya Nadella. While Microsoft (MSFT) may still be best-known to many for its Windows operating system, its Microsoft Word program and its Xbox videogame console, the company's data platform and management offerings are likely the areas where Nadella is focusing much of his attention.</p><p><blockquote>但是，这回避了一个问题：2022年微软(MSFT)可能会是什么样子，以及首席执行官塞特亚·纳德拉(Satya Nadella)的首要任务是什么。虽然微软(MSFT)可能仍然因其Windows操作系统、微软Word程序和Xbox视频游戏机而为许多人所熟知，但该公司的数据平台和管理产品可能是纳德拉关注的领域。</blockquote></p><p> That's the opinion of Morgan Stanley analyst Keith Weiss, who said that Nadella's earnings call comments \"match well to the key priorities Microsoft is investing most aggressively behind.\" Based on how data offerings such as platforms and databases like Azure are playing a role in Microsoft's (MSFT) growth, it should come as no surprise that Nadella would make such areas a focus of the company's overall strategy for the foreseeable future.</p><p><blockquote>这是摩根士丹利分析师基思·韦斯(Keith Weiss)的观点，他表示，纳德拉的财报看涨期权评论“与微软最积极投资的关键优先事项非常匹配”。基于Azure等平台和数据库等数据产品在微软(MSFT)增长中发挥的作用，纳德拉在可预见的未来将这些领域作为公司整体战略的重点也就不足为奇了。</blockquote></p><p> Weiss noted that based on industry data, Microsoft (MSFT) has become the No. 1 vendor for data management offerings, with a 28% share of the market. For comparison, Oracle (NYSE:ORCL) is the No. 2 company, with a 22% market share, and Amazon Web Services (NASDAQ:AMZN) is in third place with 9% of the data management market.</p><p><blockquote>Weiss指出，根据行业数据，微软(MSFT)已成为数据管理产品的第一大供应商，占据28%的市场份额。相比之下，甲骨文（纽约证券交易所股票代码：ORCL）以22%的市场份额位居第二，亚马逊网络服务（纳斯达克股票代码：AMZN）以9%的数据管理市场份额位居第三。</blockquote></p><p> Weiss, who has an outperform rating and $364-a-share target price on Microsoft's (MSFT) stock, noted that data platform products and services made up about 12% of the company's total revenue during the first half of 2021, up from 10% in 2017. Cloud revenue has also more than doubled over that same period, from 3% to approximately 7% of sales, and Weiss said he expects such sales to be \"a key source\" of Microsoft's business growth heading into 2022.</p><p><blockquote>Weiss对微软(MSFT)股票给予跑赢大盘评级，目标价为每股364美元，他指出，2021年上半年，数据平台产品和服务约占该公司总收入的12%，高于10%2017年。同期，云收入也增加了一倍多，从销售额的3%增加到约7%，Weiss表示，他预计此类销售额将成为微软2022年业务增长的“关键来源”。</blockquote></p><p> Weiss said that because of Microsoft's strong positioning in the data management market, and its management's high level of focus on data as part of the broader digital transformation, \"Within this data platform market, Microsoft's broad collection of cloud and on-premise data offerings lead to a No. 1 market position.\"</p><p><blockquote>Weiss表示，由于微软在数据管理市场的强大定位，以及其管理层对数据的高度关注，将其作为更广泛的数字化转型的一部分，“在这个数据平台市场中，微软广泛收集的云和本地数据产品导致了第一的市场地位。”</blockquote></p><p> Weiss, and other Morgan Stanley analysts, also rated Microsoft (MSFT) as to top pick for 2022 as part of a \"gut check\" look at the software sector for next year.</p><p><blockquote>Weiss和其他Morgan Stanley分析师还将微软(MSFT)评为2022年首选，作为对明年软件行业“直觉检查”的一部分。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Microsoft's top priority for 2022? It could be data management<blockquote>微软2022年的首要任务？可能是数据管理</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicrosoft's top priority for 2022? It could be data management<blockquote>微软2022年的首要任务？可能是数据管理</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Seeking Alpha</strong><span class=\"h-time small\">2021-12-19 08:03</span>\n</p>\n</h4>\n</header>\n<article>\n<p><a href=\"https://laohu8.com/S/MSFT\">Microsoft </a> might have its work cut out for it when it comes to improving on how things went overall for it in 2021.</p><p><blockquote><a href=\"https://laohu8.com/S/MSFT\">微软</a>在改善2021年的整体状况方面，它可能还有很多工作要做。</blockquote></p><p> After all, the software giant's earnings results continue to show it growing in areas such as cloud computing and personal computers. Microsoft (MSFT) also thinks so highly of its outlook that it believes it could surpass $50 billion in quarterly revenue for the first time with its next report. Investors should also be pleased with how Microsoft (MSFT) has performed on the stock market this year, as its shares have climbed more than 44% since the end of 2021.</p><p><blockquote>毕竟，这家软件巨头的盈利结果继续显示其在云计算和个人电脑等领域的增长。微软(MSFT)也高度评价其前景，相信在下一份报告中，其季度收入可能会首次超过500亿美元。投资者还应该对微软(MSFT)今年在股市上的表现感到满意，因为自2021年底以来，其股价已上涨超过44%。</blockquote></p><p> And then there was the symbolic, if temporary, victory Microsoft (MSFT) could claim in October when it briefly took the title of World's Most Valuable Company away from Apple (NASDAQ:AAPL). So, needless to say, 2021 has been a good year for Microsoft (MSFT).</p><p><blockquote>然后，微软(MSFT)在10月份短暂地从苹果(纳斯达克股票代码：AAPL)手中夺走了全球最有价值公司的称号，尽管是暂时的。因此，不用说，2021年对于微软(MSFT)来说是美好的一年。</blockquote></p><p> But, this begs the question of what 2022 might look like for Microsoft (MSFT), and what are going to be the top priorities for Chief Executive Satya Nadella. While Microsoft (MSFT) may still be best-known to many for its Windows operating system, its Microsoft Word program and its Xbox videogame console, the company's data platform and management offerings are likely the areas where Nadella is focusing much of his attention.</p><p><blockquote>但是，这回避了一个问题：2022年微软(MSFT)可能会是什么样子，以及首席执行官塞特亚·纳德拉(Satya Nadella)的首要任务是什么。虽然微软(MSFT)可能仍然因其Windows操作系统、微软Word程序和Xbox视频游戏机而为许多人所熟知，但该公司的数据平台和管理产品可能是纳德拉关注的领域。</blockquote></p><p> That's the opinion of Morgan Stanley analyst Keith Weiss, who said that Nadella's earnings call comments \"match well to the key priorities Microsoft is investing most aggressively behind.\" Based on how data offerings such as platforms and databases like Azure are playing a role in Microsoft's (MSFT) growth, it should come as no surprise that Nadella would make such areas a focus of the company's overall strategy for the foreseeable future.</p><p><blockquote>这是摩根士丹利分析师基思·韦斯(Keith Weiss)的观点，他表示，纳德拉的财报看涨期权评论“与微软最积极投资的关键优先事项非常匹配”。基于Azure等平台和数据库等数据产品在微软(MSFT)增长中发挥的作用，纳德拉在可预见的未来将这些领域作为公司整体战略的重点也就不足为奇了。</blockquote></p><p> Weiss noted that based on industry data, Microsoft (MSFT) has become the No. 1 vendor for data management offerings, with a 28% share of the market. For comparison, Oracle (NYSE:ORCL) is the No. 2 company, with a 22% market share, and Amazon Web Services (NASDAQ:AMZN) is in third place with 9% of the data management market.</p><p><blockquote>Weiss指出，根据行业数据，微软(MSFT)已成为数据管理产品的第一大供应商，占据28%的市场份额。相比之下，甲骨文（纽约证券交易所股票代码：ORCL）以22%的市场份额位居第二，亚马逊网络服务（纳斯达克股票代码：AMZN）以9%的数据管理市场份额位居第三。</blockquote></p><p> Weiss, who has an outperform rating and $364-a-share target price on Microsoft's (MSFT) stock, noted that data platform products and services made up about 12% of the company's total revenue during the first half of 2021, up from 10% in 2017. Cloud revenue has also more than doubled over that same period, from 3% to approximately 7% of sales, and Weiss said he expects such sales to be \"a key source\" of Microsoft's business growth heading into 2022.</p><p><blockquote>Weiss对微软(MSFT)股票给予跑赢大盘评级，目标价为每股364美元，他指出，2021年上半年，数据平台产品和服务约占该公司总收入的12%，高于10%2017年。同期，云收入也增加了一倍多，从销售额的3%增加到约7%，Weiss表示，他预计此类销售额将成为微软2022年业务增长的“关键来源”。</blockquote></p><p> Weiss said that because of Microsoft's strong positioning in the data management market, and its management's high level of focus on data as part of the broader digital transformation, \"Within this data platform market, Microsoft's broad collection of cloud and on-premise data offerings lead to a No. 1 market position.\"</p><p><blockquote>Weiss表示，由于微软在数据管理市场的强大定位，以及其管理层对数据的高度关注，将其作为更广泛的数字化转型的一部分，“在这个数据平台市场中，微软广泛收集的云和本地数据产品导致了第一的市场地位。”</blockquote></p><p> Weiss, and other Morgan Stanley analysts, also rated Microsoft (MSFT) as to top pick for 2022 as part of a \"gut check\" look at the software sector for next year.</p><p><blockquote>Weiss和其他Morgan Stanley分析师还将微软(MSFT)评为2022年首选，作为对明年软件行业“直觉检查”的一部分。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://seekingalpha.com/news/3781376-microsofts-top-priority-for-2022-it-could-be-data-management\">Seeking Alpha</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MSFT":"微软"},"source_url":"https://seekingalpha.com/news/3781376-microsofts-top-priority-for-2022-it-could-be-data-management","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1157504157","content_text":"Microsoft  might have its work cut out for it when it comes to improving on how things went overall for it in 2021.\nAfter all, the software giant's earnings results continue to show it growing in areas such as cloud computing and personal computers. Microsoft (MSFT) also thinks so highly of its outlook that it believes it could surpass $50 billion in quarterly revenue for the first time with its next report. Investors should also be pleased with how Microsoft (MSFT) has performed on the stock market this year, as its shares have climbed more than 44% since the end of 2021.\nAnd then there was the symbolic, if temporary, victory Microsoft (MSFT) could claim in October when it briefly took the title of World's Most Valuable Company away from Apple (NASDAQ:AAPL). So, needless to say, 2021 has been a good year for Microsoft (MSFT).\nBut, this begs the question of what 2022 might look like for Microsoft (MSFT), and what are going to be the top priorities for Chief Executive Satya Nadella. While Microsoft (MSFT) may still be best-known to many for its Windows operating system, its Microsoft Word program and its Xbox videogame console, the company's data platform and management offerings are likely the areas where Nadella is focusing much of his attention.\nThat's the opinion of Morgan Stanley analyst Keith Weiss, who said that Nadella's earnings call comments \"match well to the key priorities Microsoft is investing most aggressively behind.\" Based on how data offerings such as platforms and databases like Azure are playing a role in Microsoft's (MSFT) growth, it should come as no surprise that Nadella would make such areas a focus of the company's overall strategy for the foreseeable future.\nWeiss noted that based on industry data, Microsoft (MSFT) has become the No. 1 vendor for data management offerings, with a 28% share of the market. For comparison, Oracle (NYSE:ORCL) is the No. 2 company, with a 22% market share, and Amazon Web Services (NASDAQ:AMZN) is in third place with 9% of the data management market.\nWeiss, who has an outperform rating and $364-a-share target price on Microsoft's (MSFT) stock, noted that data platform products and services made up about 12% of the company's total revenue during the first half of 2021, up from 10% in 2017. Cloud revenue has also more than doubled over that same period, from 3% to approximately 7% of sales, and Weiss said he expects such sales to be \"a key source\" of Microsoft's business growth heading into 2022.\nWeiss said that because of Microsoft's strong positioning in the data management market, and its management's high level of focus on data as part of the broader digital transformation, \"Within this data platform market, Microsoft's broad collection of cloud and on-premise data offerings lead to a No. 1 market position.\"\nWeiss, and other Morgan Stanley analysts, also rated Microsoft (MSFT) as to top pick for 2022 as part of a \"gut check\" look at the software sector for next year.","news_type":1,"symbols_score_info":{"MSFT":0.9}},"isVote":1,"tweetType":1,"viewCount":1554,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600432455,"gmtCreate":1638184930164,"gmtModify":1638184930341,"author":{"id":"4094873086317940","authorId":"4094873086317940","name":"SoulMetta","avatar":"https://static.tigerbbs.com/e8ddb558fb5f336f0f9ac37f8e492989","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094873086317940","authorIdStr":"4094873086317940"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>Not going topanic 🥶 cool 😎&nbsp;","listText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>Not going topanic 🥶 cool 😎&nbsp;","text":"$SINGAPORE AIRLINES LTD(C6L.SI)$Not going topanic 🥶 cool 😎","images":[{"img":"https://static.tigerbbs.com/2ddabeecb1bbad540e6e45e4c17ac985","width":"1284","height":"2538"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600432455","isVote":1,"tweetType":1,"viewCount":1845,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":600497748,"gmtCreate":1638183987463,"gmtModify":1638183987642,"author":{"id":"4094873086317940","authorId":"4094873086317940","name":"SoulMetta","avatar":"https://static.tigerbbs.com/e8ddb558fb5f336f0f9ac37f8e492989","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094873086317940","authorIdStr":"4094873086317940"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/NVAX\">$Novavax(NVAX)$</a>sold last week and&nbsp;pocketed 🤑","listText":"<a href=\"https://laohu8.com/S/NVAX\">$Novavax(NVAX)$</a>sold last week and&nbsp;pocketed 🤑","text":"$Novavax(NVAX)$sold last week and pocketed 🤑","images":[{"img":"https://static.tigerbbs.com/cf9c81b3c94c2755bbcf81ebd90e69f9","width":"1284","height":"2538"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600497748","isVote":1,"tweetType":1,"viewCount":1678,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":600107208,"gmtCreate":1638079537115,"gmtModify":1638079537234,"author":{"id":"4094873086317940","authorId":"4094873086317940","name":"SoulMetta","avatar":"https://static.tigerbbs.com/e8ddb558fb5f336f0f9ac37f8e492989","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094873086317940","authorIdStr":"4094873086317940"},"themes":[],"title":"","htmlText":"[Smile]&nbsp;","listText":"[Smile]&nbsp;","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600107208","repostId":"2186432895","repostType":4,"isVote":1,"tweetType":1,"viewCount":1415,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875069133,"gmtCreate":1637588953971,"gmtModify":1637588953971,"author":{"id":"4094873086317940","authorId":"4094873086317940","name":"SoulMetta","avatar":"https://static.tigerbbs.com/e8ddb558fb5f336f0f9ac37f8e492989","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094873086317940","authorIdStr":"4094873086317940"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/NVAX\">$Novavax(NVAX)$</a>I was told it will go up till $279 &amp; I have been waiting 😆","listText":"<a href=\"https://laohu8.com/S/NVAX\">$Novavax(NVAX)$</a>I was told it will go up till $279 &amp; I have been waiting 😆","text":"$Novavax(NVAX)$I was told it will go up till $279 & I have been waiting 😆","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/875069133","isVote":1,"tweetType":1,"viewCount":3458,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878278105,"gmtCreate":1637201388694,"gmtModify":1637201487752,"author":{"id":"4094873086317940","authorId":"4094873086317940","name":"SoulMetta","avatar":"https://static.tigerbbs.com/e8ddb558fb5f336f0f9ac37f8e492989","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094873086317940","authorIdStr":"4094873086317940"},"themes":[],"title":"","htmlText":"[Strong]&nbsp;[Strong]&nbsp;","listText":"[Strong]&nbsp;[Strong]&nbsp;","text":"[Strong] [Strong]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/878278105","repostId":"1155680084","repostType":4,"isVote":1,"tweetType":1,"viewCount":1581,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":843180044,"gmtCreate":1635812830436,"gmtModify":1635812830506,"author":{"id":"4094873086317940","authorId":"4094873086317940","name":"SoulMetta","avatar":"https://static.tigerbbs.com/e8ddb558fb5f336f0f9ac37f8e492989","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094873086317940","authorIdStr":"4094873086317940"},"themes":[],"title":"","htmlText":"Waiting for you","listText":"Waiting for you","text":"Waiting for you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/843180044","repostId":"1118798908","repostType":4,"repost":{"id":"1118798908","kind":"news","pubTimestamp":1635810877,"share":"https://www.laohu8.com/m/news/1118798908?lang=zh_CN&edition=full","pubTime":"2021-11-02 07:54","market":"us","language":"en","title":"Novavax COVID-19 vaccine gets first authorization; expects more within weeks, CEO says<blockquote>Novavax新冠肺炎疫苗获得首次授权；首席执行官表示，预计几周内会有更多</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1118798908","media":"Reuters","summary":"(Reuters) -Novavax Inc expects regulators in India, the Philippines and elsewhere to make a decision","content":"<p>(Reuters) -Novavax Inc expects regulators in India, the Philippines and elsewhere to make a decision on its COVID-19 vaccine within “weeks,” its chief executive told Reuters, after the shot on Monday received its first emergency use authorization (EUA) from Indonesia.</p><p><blockquote>(路透社）--诺瓦瓦克斯公司（Novavax Inc）首席执行官告诉路透社，该公司预计印度、菲律宾和其他地方的监管机构将在 “几周内 ”内就其 COVID-19 疫苗做出决定。</blockquote></p><p> FILE PHOTO: A woman holds a small bottle labeled with a \"Coronavirus COVID-19 Vaccine\" sticker and a medical syringe in front of displayed Novavax logo in this illustration taken, October 30, 2020. REUTERS/Dado Ruvic</p><p><blockquote>资料照片：在这张拍摄于2020年10月30日的插图中，一名妇女拿着一个贴有“冠状病毒新冠肺炎疫苗”标签的小瓶子和一个医用注射器，在展示的Novavax标志前。路透社/达多·鲁维奇</blockquote></p><p> Novavax shares were up about 13% after the company also said it had filed an application for emergency use of the vaccine to Canada and the European Medicines Agency.</p><p><blockquote>Novavax 股价上涨约 13%，此前该公司还表示已向加拿大和欧洲药品管理局提交了紧急使用疫苗的申请。</blockquote></p><p> For Indonesia, the shot will be manufactured by the world’s largest vaccine manufacturer, Serum Institute in India (SII), and sold under the Indian company’s brand name, Covovax. Novavax said initial shipments into Indonesia are expected to begin imminently.</p><p><blockquote>对于印度尼西亚来说，这种疫苗将由世界上最大的疫苗制造商印度血清研究所（SII）生产，并以印度公司 Covovax 的品牌名称销售。Novavax 表示，预计即将开始向印度尼西亚发货。</blockquote></p><p> The World Health Organization (WHO) is also reviewing Novavax’s regulatory filing and the U.S. drugmaker expects that review to be resolved in the coming weeks, Chief Executive Stanley Erck told Reuters in a phone interview on Monday.</p><p><blockquote>世界卫生组织（WHO）首席执行官斯坦利-埃克（Stanley Erck）周一在接受路透社电话采访时表示，世界卫生组织（WHO）也在审查 Novavax 的监管文件，这家美国制药商预计审查将在未来几周内得到解决。</blockquote></p><p> A green light from the WHO would set the stage for Novavax to begin shipping doses to the COVAX program that supplies shots to low-income countries. Novavax and SII have together committed to provide more than 1.1 billion doses to COVAX, which is co-led by the WHO.</p><p><blockquote>世卫组织的绿灯将为 Novavax 开始向 COVAX 计划运送疫苗奠定基础，该计划为低收入国家提供疫苗。Novavax 和 SII 共同承诺向世卫组织共同领导的 COVAX 提供超过 11 亿剂疫苗。</blockquote></p><p> “I think we’ll get some doses to COVAX this year,” Erck said. “But I think (Novavax is) going to really start being able to ship large quantity to COVAX in the first quarter” of 2022.</p><p><blockquote>“埃尔克说：”我认为我们今年会给 COVAX 提供一些剂量。“但我认为（Novavax）将在2022年第一季度真正开始能够向COVAX运送大量物资”。</blockquote></p><p> Erck said Novavax has resolved all of its manufacturing challenges and does not expect regulators to have any further concerns about its production processes.</p><p><blockquote>Erck表示，Novavax已经解决了所有制造挑战，预计监管机构不会对其生产流程有任何进一步的担忧。</blockquote></p><p> He said Novavax is “in dialogue with the U.S. FDA and ... we expect a full submission within the next several weeks.”</p><p><blockquote>他说，Novavax 正在 “与美国食品及药物管理局进行对话......我们预计将在未来几周内提交完整的材料”。</blockquote></p><p> Novavax had delayed filing for U.S. approval, and Politico reported last month that the company faced production and quality problems.</p><p><blockquote>Novavax 已推迟提交美国批准申请，Politico 上个月报道称，该公司面临生产和质量问题。</blockquote></p><p> SII is authorized to make the Novavax vaccine and the U.S. company said it will apply for regulatory authorization for other facilities, such as its plant in the Czech republic, in the coming weeks.</p><p><blockquote>SII 被授权生产 Novavax 疫苗，这家美国公司表示将在未来几周内为其他工厂申请监管部门授权，例如其在捷克共和国的工厂。</blockquote></p><p> Indonesia is slated to receive 20 million doses of the protein-based vaccine this year, according to the government.</p><p><blockquote>据印度尼西亚政府称，印度尼西亚今年将收到 2000 万剂基于蛋白质的疫苗。</blockquote></p><p> Penny Lukito, chief of the National Agency for Drug and Food Control of Indonesia, did not immediately respond to a Reuters request for comment.</p><p><blockquote>印度尼西亚国家药品和食品控制局局长彭妮·卢基托没有立即回应路透社的置评请求。</blockquote></p><p> Novavax has so far applied for EUA in various countries, including the UK, Australia, India and the Philippines.</p><p><blockquote>迄今为止，Novavax已在英国、澳大利亚、印度和菲律宾等多个国家申请EUA。</blockquote></p><p> “It will be weeks, not months, for them to review” Novavax’s regulatory submissions and potentially clear the shot for use, Erck said.</p><p><blockquote>埃尔克说：“他们需要几周时间，而不是几个月的时间来审查 ”Novavax 提交的监管文件，并有可能批准使用疫苗。</blockquote></p><p> The company, along with Japanese partner Takeda Pharmaceutical Co, said on Friday it was preparing to seek regulatory approval for a rollout in Japan early next year.</p><p><blockquote>该公司及其日本合作伙伴武田制药公司周五表示，正准备寻求监管部门批准明年初在日本推出该产品。</blockquote></p><p> The Novavax shot was shown to be more than 90% effective, including against a variety of concerning variants of the coronavirus in a large, late-stage U.S.-based trial.</p><p><blockquote>Novavax注射被证明有90%以上的有效性，包括在美国的一项大型后期试验中针对各种令人担忧的冠状病毒变种。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax COVID-19 vaccine gets first authorization; expects more within weeks, CEO says<blockquote>Novavax新冠肺炎疫苗获得首次授权；首席执行官表示，预计几周内会有更多</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax COVID-19 vaccine gets first authorization; expects more within weeks, CEO says<blockquote>Novavax新冠肺炎疫苗获得首次授权；首席执行官表示，预计几周内会有更多</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-11-02 07:54</span>\n</p>\n</h4>\n</header>\n<article>\n<p>(Reuters) -Novavax Inc expects regulators in India, the Philippines and elsewhere to make a decision on its COVID-19 vaccine within “weeks,” its chief executive told Reuters, after the shot on Monday received its first emergency use authorization (EUA) from Indonesia.</p><p><blockquote>(路透社）--诺瓦瓦克斯公司（Novavax Inc）首席执行官告诉路透社，该公司预计印度、菲律宾和其他地方的监管机构将在 “几周内 ”内就其 COVID-19 疫苗做出决定。</blockquote></p><p> FILE PHOTO: A woman holds a small bottle labeled with a \"Coronavirus COVID-19 Vaccine\" sticker and a medical syringe in front of displayed Novavax logo in this illustration taken, October 30, 2020. REUTERS/Dado Ruvic</p><p><blockquote>资料照片：在这张拍摄于2020年10月30日的插图中，一名妇女拿着一个贴有“冠状病毒新冠肺炎疫苗”标签的小瓶子和一个医用注射器，在展示的Novavax标志前。路透社/达多·鲁维奇</blockquote></p><p> Novavax shares were up about 13% after the company also said it had filed an application for emergency use of the vaccine to Canada and the European Medicines Agency.</p><p><blockquote>Novavax 股价上涨约 13%，此前该公司还表示已向加拿大和欧洲药品管理局提交了紧急使用疫苗的申请。</blockquote></p><p> For Indonesia, the shot will be manufactured by the world’s largest vaccine manufacturer, Serum Institute in India (SII), and sold under the Indian company’s brand name, Covovax. Novavax said initial shipments into Indonesia are expected to begin imminently.</p><p><blockquote>对于印度尼西亚来说，这种疫苗将由世界上最大的疫苗制造商印度血清研究所（SII）生产，并以印度公司 Covovax 的品牌名称销售。Novavax 表示，预计即将开始向印度尼西亚发货。</blockquote></p><p> The World Health Organization (WHO) is also reviewing Novavax’s regulatory filing and the U.S. drugmaker expects that review to be resolved in the coming weeks, Chief Executive Stanley Erck told Reuters in a phone interview on Monday.</p><p><blockquote>世界卫生组织（WHO）首席执行官斯坦利-埃克（Stanley Erck）周一在接受路透社电话采访时表示，世界卫生组织（WHO）也在审查 Novavax 的监管文件，这家美国制药商预计审查将在未来几周内得到解决。</blockquote></p><p> A green light from the WHO would set the stage for Novavax to begin shipping doses to the COVAX program that supplies shots to low-income countries. Novavax and SII have together committed to provide more than 1.1 billion doses to COVAX, which is co-led by the WHO.</p><p><blockquote>世卫组织的绿灯将为 Novavax 开始向 COVAX 计划运送疫苗奠定基础，该计划为低收入国家提供疫苗。Novavax 和 SII 共同承诺向世卫组织共同领导的 COVAX 提供超过 11 亿剂疫苗。</blockquote></p><p> “I think we’ll get some doses to COVAX this year,” Erck said. “But I think (Novavax is) going to really start being able to ship large quantity to COVAX in the first quarter” of 2022.</p><p><blockquote>“埃尔克说：”我认为我们今年会给 COVAX 提供一些剂量。“但我认为（Novavax）将在2022年第一季度真正开始能够向COVAX运送大量物资”。</blockquote></p><p> Erck said Novavax has resolved all of its manufacturing challenges and does not expect regulators to have any further concerns about its production processes.</p><p><blockquote>Erck表示，Novavax已经解决了所有制造挑战，预计监管机构不会对其生产流程有任何进一步的担忧。</blockquote></p><p> He said Novavax is “in dialogue with the U.S. FDA and ... we expect a full submission within the next several weeks.”</p><p><blockquote>他说，Novavax 正在 “与美国食品及药物管理局进行对话......我们预计将在未来几周内提交完整的材料”。</blockquote></p><p> Novavax had delayed filing for U.S. approval, and Politico reported last month that the company faced production and quality problems.</p><p><blockquote>Novavax 已推迟提交美国批准申请，Politico 上个月报道称，该公司面临生产和质量问题。</blockquote></p><p> SII is authorized to make the Novavax vaccine and the U.S. company said it will apply for regulatory authorization for other facilities, such as its plant in the Czech republic, in the coming weeks.</p><p><blockquote>SII 被授权生产 Novavax 疫苗，这家美国公司表示将在未来几周内为其他工厂申请监管部门授权，例如其在捷克共和国的工厂。</blockquote></p><p> Indonesia is slated to receive 20 million doses of the protein-based vaccine this year, according to the government.</p><p><blockquote>据印度尼西亚政府称，印度尼西亚今年将收到 2000 万剂基于蛋白质的疫苗。</blockquote></p><p> Penny Lukito, chief of the National Agency for Drug and Food Control of Indonesia, did not immediately respond to a Reuters request for comment.</p><p><blockquote>印度尼西亚国家药品和食品控制局局长彭妮·卢基托没有立即回应路透社的置评请求。</blockquote></p><p> Novavax has so far applied for EUA in various countries, including the UK, Australia, India and the Philippines.</p><p><blockquote>迄今为止，Novavax已在英国、澳大利亚、印度和菲律宾等多个国家申请EUA。</blockquote></p><p> “It will be weeks, not months, for them to review” Novavax’s regulatory submissions and potentially clear the shot for use, Erck said.</p><p><blockquote>埃尔克说：“他们需要几周时间，而不是几个月的时间来审查 ”Novavax 提交的监管文件，并有可能批准使用疫苗。</blockquote></p><p> The company, along with Japanese partner Takeda Pharmaceutical Co, said on Friday it was preparing to seek regulatory approval for a rollout in Japan early next year.</p><p><blockquote>该公司及其日本合作伙伴武田制药公司周五表示，正准备寻求监管部门批准明年初在日本推出该产品。</blockquote></p><p> The Novavax shot was shown to be more than 90% effective, including against a variety of concerning variants of the coronavirus in a large, late-stage U.S.-based trial.</p><p><blockquote>Novavax注射被证明有90%以上的有效性，包括在美国的一项大型后期试验中针对各种令人担忧的冠状病毒变种。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.reuters.com/article/health-coronavirus-novavax/update-3-novavax-covid-19-vaccine-gets-first-authorization-expects-more-within-weeks-ceo-says-idUSL4N2RS2MV\">Reuters</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://www.reuters.com/article/health-coronavirus-novavax/update-3-novavax-covid-19-vaccine-gets-first-authorization-expects-more-within-weeks-ceo-says-idUSL4N2RS2MV","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1118798908","content_text":"(Reuters) -Novavax Inc expects regulators in India, the Philippines and elsewhere to make a decision on its COVID-19 vaccine within “weeks,” its chief executive told Reuters, after the shot on Monday received its first emergency use authorization (EUA) from Indonesia.\nFILE PHOTO: A woman holds a small bottle labeled with a \"Coronavirus COVID-19 Vaccine\" sticker and a medical syringe in front of displayed Novavax logo in this illustration taken, October 30, 2020. REUTERS/Dado Ruvic\nNovavax shares were up about 13% after the company also said it had filed an application for emergency use of the vaccine to Canada and the European Medicines Agency.\nFor Indonesia, the shot will be manufactured by the world’s largest vaccine manufacturer, Serum Institute in India (SII), and sold under the Indian company’s brand name, Covovax. Novavax said initial shipments into Indonesia are expected to begin imminently.\nThe World Health Organization (WHO) is also reviewing Novavax’s regulatory filing and the U.S. drugmaker expects that review to be resolved in the coming weeks, Chief Executive Stanley Erck told Reuters in a phone interview on Monday.\nA green light from the WHO would set the stage for Novavax to begin shipping doses to the COVAX program that supplies shots to low-income countries. Novavax and SII have together committed to provide more than 1.1 billion doses to COVAX, which is co-led by the WHO.\n“I think we’ll get some doses to COVAX this year,” Erck said. “But I think (Novavax is) going to really start being able to ship large quantity to COVAX in the first quarter” of 2022.\nErck said Novavax has resolved all of its manufacturing challenges and does not expect regulators to have any further concerns about its production processes.\nHe said Novavax is “in dialogue with the U.S. FDA and ... we expect a full submission within the next several weeks.”\nNovavax had delayed filing for U.S. approval, and Politico reported last month that the company faced production and quality problems.\nSII is authorized to make the Novavax vaccine and the U.S. company said it will apply for regulatory authorization for other facilities, such as its plant in the Czech republic, in the coming weeks.\nIndonesia is slated to receive 20 million doses of the protein-based vaccine this year, according to the government.\nPenny Lukito, chief of the National Agency for Drug and Food Control of Indonesia, did not immediately respond to a Reuters request for comment.\nNovavax has so far applied for EUA in various countries, including the UK, Australia, India and the Philippines.\n“It will be weeks, not months, for them to review” Novavax’s regulatory submissions and potentially clear the shot for use, Erck said.\nThe company, along with Japanese partner Takeda Pharmaceutical Co, said on Friday it was preparing to seek regulatory approval for a rollout in Japan early next year.\nThe Novavax shot was shown to be more than 90% effective, including against a variety of concerning variants of the coronavirus in a large, late-stage U.S.-based trial.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":1552,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":843116343,"gmtCreate":1635812641893,"gmtModify":1635812641959,"author":{"id":"4094873086317940","authorId":"4094873086317940","name":"SoulMetta","avatar":"https://static.tigerbbs.com/e8ddb558fb5f336f0f9ac37f8e492989","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094873086317940","authorIdStr":"4094873086317940"},"themes":[],"title":"","htmlText":"Tesla over priced. Short term","listText":"Tesla over priced. Short term","text":"Tesla over priced. Short term","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/843116343","repostId":"2180209403","repostType":4,"isVote":1,"tweetType":1,"viewCount":1503,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":853530637,"gmtCreate":1634823269451,"gmtModify":1634823269566,"author":{"id":"4094873086317940","authorId":"4094873086317940","name":"SoulMetta","avatar":"https://static.tigerbbs.com/e8ddb558fb5f336f0f9ac37f8e492989","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094873086317940","authorIdStr":"4094873086317940"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/GOLD\">$Barrick Gold Corp(GOLD)$</a>Going up up up","listText":"<a href=\"https://laohu8.com/S/GOLD\">$Barrick Gold Corp(GOLD)$</a>Going up up up","text":"$Barrick Gold Corp(GOLD)$Going up up up","images":[{"img":"https://static.tigerbbs.com/3a3f8593131da853ab91014442db0a97","width":"1284","height":"2538"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/853530637","isVote":1,"tweetType":1,"viewCount":1455,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":825140977,"gmtCreate":1634212850368,"gmtModify":1634212850415,"author":{"id":"4094873086317940","authorId":"4094873086317940","name":"SoulMetta","avatar":"https://static.tigerbbs.com/e8ddb558fb5f336f0f9ac37f8e492989","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094873086317940","authorIdStr":"4094873086317940"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/GOLD\">$Barrick Gold Corp(GOLD)$</a>💪🏻","listText":"<a href=\"https://laohu8.com/S/GOLD\">$Barrick Gold Corp(GOLD)$</a>💪🏻","text":"$Barrick Gold Corp(GOLD)$💪🏻","images":[{"img":"https://static.tigerbbs.com/40032e8e942eedfaf2c354fc2ad5aa62","width":"1125","height":"3621"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/825140977","isVote":1,"tweetType":1,"viewCount":1726,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"defaultTab":"followers","isTTM":false}